Skip to main content
Equibles
HTFL logo

HTFL · Heartflow, Inc. · Metrics

Track HTFL — free

Use HTFL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HTFL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$57.08 +1.65 (+2.98%)
Russell 2000 member Rebalance outlook locked
Market Cap
$4.82B
Shares
86.95M
Volume · Oct 23 756.52K Avg daily vol (3M) 1.86M

HTFL metrics

76 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$55.43
Market cap
$4.82B

Price action

20 metrics
Price change (1W)
+8.9%
Price change (30D)
+10.5%
Price change (3M)
+125.2%
Price change (6M)
+77.4%
Price change (YTD)
+90.2%
Price change (1Y)
+41.0%
Trailing year
Price change (5Y)
—
52-week high
$55.82
52-week low
$20.49
Change from 52-week high
-0.7%
Change from 52-week low
+170.5%
Annualized volatility
78.1%
Annualized volatility (3M)
85.5%
Beta
1.9
RSI (14D)
64.3
Price vs SMA 50
+13.4%
Price vs SMA 200
+66.2%
Avg volume (3M)
1.86M
Relative volume
0.7
Average dollar volume
$85.10M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
86.95M

Valuation

12 metrics
P / E (TTM)
18.2
Trailing earnings · reciprocal yield 5.5%
PEG ratio
—
EV / revenue
22.1×
reciprocal yield 4.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
22.9×
reciprocal yield 4.4%
P / book
17.4
reciprocal yield 5.8%
FCF yield
-1.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-12
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
80.1%
Operating margin
-37.8%
Trailing 12 months
Net margin
-55.8%
Gross profit (TTM)
$169.83M
Operating profit (TTM)
−$80.25M
Net income (TTM)
−$118.37M
Trailing 12 months
Diluted EPS (TTM)
$3.04
FCF margin
-27.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.53

Growth

11 metrics
Revenue growth YoY
+47.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$212.07M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,267.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-42.3%
Return on assets
-34.4%
Debt / equity
0.0
Current ratio
5.1
EBITDA (TTM)
−$74.94M
Free cash flow (TTM)
−$59.18M
Quick ratio
5.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$162.55M
Latest balance sheet
Cash & equivalents
$34.36M
Total assets
$344.46M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$52.23M
Capital expenditures (TTM)
$6.95M
R&D (TTM)
$83.84M
SG&A (TTM)
$158.76M
Stock compensation (TTM)
$23.69M
R&D / revenue
39.5%
Stock compensation / revenue
11.2%

Ownership (13F)

9 metrics
13F filers
194
13F filer change QoQ
+25
Institutional ownership
86.3%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
20.0%
Private-fund adviser ownership
19.6%
Active holders' share change QoQ
+0.3%
Holder tenure
3.4
Price vs estimated holder cost
-3.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.5%

Short interest

3 metrics
Short interest
7.8%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$14.17M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1464521 CUSIP 42238D107 13F (30d) 27 filings 27 filers Visit website Investor relations